Kaplan Fox Notifies Investors of Hims & Hers Health, Inc. (NYSE: HIMS) of a Securities Fraud Class Action Deadline on November 2, 2026

Kaplan Fox has filed a securities class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased securities between August 4, 2025 and July 29, 2026. The FTC sued the company for allegedly failing to disclose immediate prescription charges, making subscription cancellations difficult, and sharing consumers' health information with third-party advertising platforms like Meta and Snap. The stock fell 14.73% to $25.00 per share following the FTC action. The lead plaintiff deadline is November 2, 2026.